178 related articles for article (PubMed ID: 28381109)
1. Prostanoid-dependent spontaneous pain and PAR
Ito M; Ono K; Hitomi S; Nodai T; Sago T; Yamaguchi K; Harano N; Gunnjigake K; Hosokawa R; Kawamoto T; Inenaga K
Mol Pain; 2017 Jan; 13():1744806917704138. PubMed ID: 28381109
[TBL] [Abstract][Full Text] [Related]
2. Endothelin-1 Elicits TRP-Mediated Pain in an Acid-Induced Oral Ulcer Model.
Nodai T; Hitomi S; Ono K; Masaki C; Harano N; Morii A; Sago-Ito M; Ujihara I; Hibino T; Terawaki K; Omiya Y; Hosokawa R; Inenaga K
J Dent Res; 2018 Jul; 97(8):901-908. PubMed ID: 29518348
[TBL] [Abstract][Full Text] [Related]
3. Distinct TRPV1- and TRPA1-based mechanisms underlying enhancement of oral ulcerative mucositis-induced pain by 5-fluorouracil.
Yamaguchi K; Ono K; Hitomi S; Ito M; Nodai T; Goto T; Harano N; Watanabe S; Inoue H; Miyano K; Uezono Y; Matoba M; Inenaga K
Pain; 2016 May; 157(5):1004-1020. PubMed ID: 26808144
[TBL] [Abstract][Full Text] [Related]
4. Involvement of TRPV1 and TRPA1 in incisional intraoral and extraoral pain.
Urata K; Shinoda M; Honda K; Lee J; Maruno M; Ito R; Gionhaku N; Iwata K
J Dent Res; 2015 Mar; 94(3):446-54. PubMed ID: 25576470
[TBL] [Abstract][Full Text] [Related]
5. Protease-activated receptor 2 sensitizes the transient receptor potential vanilloid 4 ion channel to cause mechanical hyperalgesia in mice.
Grant AD; Cottrell GS; Amadesi S; Trevisani M; Nicoletti P; Materazzi S; Altier C; Cenac N; Zamponi GW; Bautista-Cruz F; Lopez CB; Joseph EK; Levine JD; Liedtke W; Vanner S; Vergnolle N; Geppetti P; Bunnett NW
J Physiol; 2007 Feb; 578(Pt 3):715-33. PubMed ID: 17124270
[TBL] [Abstract][Full Text] [Related]
6. TRPA1 and TRPV4 mediate paclitaxel-induced peripheral neuropathy in mice via a glutathione-sensitive mechanism.
Materazzi S; Fusi C; Benemei S; Pedretti P; Patacchini R; Nilius B; Prenen J; Creminon C; Geppetti P; Nassini R
Pflugers Arch; 2012 Apr; 463(4):561-9. PubMed ID: 22258694
[TBL] [Abstract][Full Text] [Related]
7. The tyrosine kinase inhibitor bafetinib inhibits PAR2-induced activation of TRPV4 channels in vitro and pain in vivo.
Grace MS; Lieu T; Darby B; Abogadie FC; Veldhuis N; Bunnett NW; McIntyre P
Br J Pharmacol; 2014 Aug; 171(16):3881-94. PubMed ID: 24779362
[TBL] [Abstract][Full Text] [Related]
8. Hypersensitivity Induced by Activation of Spinal Cord PAR2 Receptors Is Partially Mediated by TRPV1 Receptors.
Mrozkova P; Spicarova D; Palecek J
PLoS One; 2016; 11(10):e0163991. PubMed ID: 27755539
[TBL] [Abstract][Full Text] [Related]
9. Antinociceptive activity of transient receptor potential channel TRPV1, TRPA1, and TRPM8 antagonists in neurogenic and neuropathic pain models in mice.
Sałat K; Filipek B
J Zhejiang Univ Sci B; 2015 Mar; 16(3):167-78. PubMed ID: 25743118
[TBL] [Abstract][Full Text] [Related]
10. A prostaglandin E2 receptor subtype EP1 receptor antagonist (ONO-8711) reduces hyperalgesia, allodynia, and c-fos gene expression in rats with chronic nerve constriction.
Kawahara H; Sakamoto A; Takeda S; Onodera H; Imaki J; Ogawa R
Anesth Analg; 2001 Oct; 93(4):1012-7. PubMed ID: 11574375
[TBL] [Abstract][Full Text] [Related]
11. Proteinase-activated receptor 2 sensitizes transient receptor potential vanilloid 1, transient receptor potential vanilloid 4, and transient receptor potential ankyrin 1 in paclitaxel-induced neuropathic pain.
Chen Y; Yang C; Wang ZJ
Neuroscience; 2011 Oct; 193():440-51. PubMed ID: 21763756
[TBL] [Abstract][Full Text] [Related]
12. Neutrophil Elastase Activates Protease-activated Receptor-2 (PAR2) and Transient Receptor Potential Vanilloid 4 (TRPV4) to Cause Inflammation and Pain.
Zhao P; Lieu T; Barlow N; Sostegni S; Haerteis S; Korbmacher C; Liedtke W; Jimenez-Vargas NN; Vanner SJ; Bunnett NW
J Biol Chem; 2015 May; 290(22):13875-87. PubMed ID: 25878251
[TBL] [Abstract][Full Text] [Related]
13. Non-steroidal anti-inflammatory drugs attenuate agonist-evoked activation of transient receptor potential channels.
Tsagareli MG; Nozadze I; Tsiklauri N; Gurtskaia G
Biomed Pharmacother; 2018 Jan; 97():745-751. PubMed ID: 29102918
[TBL] [Abstract][Full Text] [Related]
14. Participation of peripheral TRPV1, TRPV4, TRPA1 and ASIC in a magnesium sulfate-induced local pain model in rat.
Srebro D; Vučković S; Prostran M
Neuroscience; 2016 Dec; 339():1-11. PubMed ID: 27687800
[TBL] [Abstract][Full Text] [Related]
15. Prostanoid-dependent bladder pain caused by proteinase-activated receptor-2 activation in mice: Involvement of TRPV1 and T-type Ca
Tsubota M; Ozaki T; Hayashi Y; Okawa Y; Fujimura A; Sekiguchi F; Nishikawa H; Kawabata A
J Pharmacol Sci; 2018 Jan; 136(1):46-49. PubMed ID: 29289470
[TBL] [Abstract][Full Text] [Related]
16. Sensitisation of TRPV4 by PAR2 is independent of intracellular calcium signalling and can be mediated by the biased agonist neutrophil elastase.
Sostegni S; Diakov A; McIntyre P; Bunnett N; Korbmacher C; Haerteis S
Pflugers Arch; 2015 Apr; 467(4):687-701. PubMed ID: 24906497
[TBL] [Abstract][Full Text] [Related]
17. Involvement of transient receptor potential vanilloid 1 receptors in protease-activated receptor-2-induced joint inflammation and nociception.
Helyes Z; Sándor K; Borbély E; Tékus V; Pintér E; Elekes K; Tóth DM; Szolcsányi J; McDougall JJ
Eur J Pain; 2010 Apr; 14(4):351-8. PubMed ID: 19683949
[TBL] [Abstract][Full Text] [Related]
18. Involvement of TRPV1 in nociceptive behavior in a rat model of cancer pain.
Shinoda M; Ogino A; Ozaki N; Urano H; Hironaka K; Yasui M; Sugiura Y
J Pain; 2008 Aug; 9(8):687-99. PubMed ID: 18455478
[TBL] [Abstract][Full Text] [Related]
19. Oxidative stress mediates thalidomide-induced pain by targeting peripheral TRPA1 and central TRPV4.
De Logu F; Trevisan G; Marone IM; Coppi E; Padilha Dalenogare D; Titiz M; Marini M; Landini L; Souza Monteiro de Araujo D; Li Puma S; Materazzi S; De Siena G; Geppetti P; Nassini R
BMC Biol; 2020 Dec; 18(1):197. PubMed ID: 33317522
[TBL] [Abstract][Full Text] [Related]
20. Thermal Hyperalgesia and Mechanical Allodynia Elicited by Histamine and Non-histaminergic Itch Mediators: Respective Involvement of TRPV1 and TRPA1.
Tsagareli MG; Nozadze I; Tsiklauri N; Carstens MI; Gurtskaia G; Carstens E
Neuroscience; 2020 Nov; 449():35-45. PubMed ID: 33010342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
